PYCR2 promotes growth and aerobic glycolysis in human liver cancer by regulating the AKT signaling pathway.

Wang, Shaoyan; Yi, Wenyan; Xu, Zhenyu; Shi, Minyu

Wang, Shaoyan; Yi, Wenyan; Xu, Zhenyu; Shi, Minyu.

Affiliation

Wang S; Department of Infectious Diseases, Seventh People's Hospital of Shanghai University of Traditional Chinese Medicine, Shanghai, 200137, China.
Yi W; Department of Emergency Internal Medicine, Seventh People's Hospital of Shanghai University of Traditional Chinese Medicine, Shanghai, 200137, China.
Xu Z; Department of Emergency Internal Medicine, Seventh People's Hospital of Shanghai University of Traditional Chinese Medicine, Shanghai, 200137, China.
Shi M; Department of Infectious Diseases, Seventh People's Hospital of Shanghai University of Traditional Chinese Medicine, Shanghai, 200137, China. Electronic address: shiminyu303@163.com.

Biochem Biophys Res Commun ; 680: 15-24, 2023 11 05.

Article de En | MEDLINE | ID: mdl-37708598

Sujet(s)
Mots clés

AKT signaling pathway; Glycolysis; Hepatocellular carcinoma; PYCR2

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Carcinome hépatocellulaire / Tumeurs du foie Type d'étude: Prognostic_studies Limites: Animals / Humans Langue: En Journal: Biochem Biophys Res Commun Année: 2023 Type de document: Article Pays d'affiliation: Chine

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google